Abvc Biopharma annual free cash flow
2010
2011
2012
2013
2021
2022
2023
Abvc Biopharma Free Cash Flow (FCF) History (ABVC)
Abvc Biopharma reported −$4.2M in free cash flow for fiscal 2023, an increase of $3.3M from the previous fiscal year, with a free cash flow margin of −2760.64%.
View full Abvc Biopharma company overviewAbvc Biopharma free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2023 | 2023-12-31 | −$4.2M | $3.3M | — | −2760.64% |
| 2022 | 2022-12-31 | −$7.5M | $97,139 | — | −775.23% |
| 2021 | 2021-12-31 | −$7.6M | — | — | −2140.33% |
| 2013 | 2013-09-30 | −$37,768 | $877,706 | — | −485.01% |
| 2012 | 2012-09-30 | −$915,474 | $707,525 | — | −16021.60% |
| 2011 | 2011-09-30 | −$1.6M | −$574,364 | — | −50877.71% |
| 2010 | 2010-09-30 | −$1.0M | — | — | −7056.76% |
Abvc Biopharma quarterly free cash flow
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.22
Q2.22
Q3.22
Q4.22
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2022 | 2022-12-31 | −$461,158 | — | — | −78.30% |
| Q3 2022 | 2022-09-30 | −$518,061 | — | — | −1225.63% |
| Q2 2022 | 2022-06-30 | −$3.5M | — | — | −1103.17% |
| Q1 2022 | 2022-03-31 | −$3.1M | — | — | −12032.26% |
| Q4 2013 | 2013-09-30 | $0 | $94,168 | — | — |
| Q3 2013 | 2013-06-30 | −$170 | $238,471 | — | — |
| Q2 2013 | 2013-03-31 | −$1,248 | $214,437 | — | −163.99% |
| Q1 2013 | 2012-12-31 | −$36,350 | $330,630 | — | −517.36% |
| Q4 2012 | 2012-09-30 | −$94,168 | $231,282 | — | — |
| Q3 2012 | 2012-06-30 | −$238,641 | $104,062 | — | — |
| Q2 2012 | 2012-03-31 | −$215,685 | $584,568 | — | −5884.99% |
| Q1 2012 | 2011-12-31 | −$366,980 | −$212,387 | — | −17910.20% |
| Q4 2011 | 2011-09-30 | −$325,450 | — | — | — |
| Q3 2011 | 2011-06-30 | −$342,703 | — | — | — |
| Q2 2011 | 2011-03-31 | −$800,253 | — | — | −111146.25% |
| Q1 2011 | 2010-12-31 | −$154,593 | — | — | −6258.83% |
Abvc Biopharma free cash flow growth trends
Abvc Biopharma's latest reported quarter, Q4 2022, generated −$461,158 in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Abvc Biopharma source filings ↗